Dr. Nagourney's Blog

Serendipity Saves a Life for a Patient with Advanced Breast Cancer

In early September of 2018, I consulted with a 51-year-old patient with heavily pre-treated, extremely advanced metastatic breast cancer. Diagnosed 5 years earlier, the tumor was managed by targeting the HER-2 oncogene identified in her...

For Some Cancers Are There Immunotherapy Hazards?

A report by French investigators has raised concern regarding the broad application of immunotherapy in lung cancer. Checkpoint...

Cancer, Computers and Genes: A Bad Mix for Patients

Every day, we hear of another breakthrough using gene testing and DNA to identify a new target, new treatment, new combination...

High Cost of Cancer Care To 340B or Not To 340B, That Is The Question?

There are many reasons why medical care costs continue to spiral out of control. Some of these are systemic like an aging...

The Right Treatment at the Right Time: Double-Hit Lymphoma

On February 5th, 2018 I was asked to consult on a 53-year-old patient who was admitted to the hospital with a one month’s...

Cancer Patients and the "Right To Try"

On May 30, 2018 the president signed HR 878, granting terminally ill patients the right to try experimental drugs. While there...

Cancer Patients Want to Win, but is the Playing Field Level?

Anyone diagnosed with cancer knows the drill. After the initial shock, many go to the internet in pursuit of honest and...